Acumen Pharmaceuticals (ABOS) Current Assets (2020 - 2026)

Acumen Pharmaceuticals' Current Assets history runs 7 years deep, the most recent figure standing at $133.1 million for Q1 2026.

• In Q1 2026, Current Assets fell 14.1% year-over-year to $133.1 million; the TTM figure through Mar 2026 stood at $133.1 million (down 14.1% YoY), while the FY2025 annual figure was $122.3 million, down 31.44% from the prior year.
• Current Assets came in at $133.1 million for Q1 2026 at Acumen Pharmaceuticals, up from $122.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $266.9 million in Q2 2024 to a low of $122.3 million in Q4 2025.
• A 5-year average of $183.8 million and a median of $180.3 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 170.72% in 2022 and sank 44.4% in 2025, its largest moves.
• Acumen Pharmaceuticals' Current Assets stood at $180.3 million in 2022, then jumped by 36.76% to $246.6 million in 2023, then decreased by 27.7% to $178.3 million in 2024, then plunged by 31.44% to $122.3 million in 2025, then rose by 8.87% to $133.1 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $133.1 million, $122.3 million, and $132.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison